Matrix Metalloproteinase-1 Polymorphism (-1607G) and Disease Severity in Non-Cystic Fibrosis Bronchiectasis in Taiwan

Objectives Bronchiectasis is characterized by an irreversible dilatation of bronchi and is associated with lung fibrosis. MMP-1 polymorphism may alter its transcriptional activity, and differentially modulate bronchial destruction and lung fibrosis. Design To investigate the association of MMP-1 polymorphisms with disease severity in non-cystic fibrosis (CF) bronchiectasis patients, 51 normal subjects and 113 patients with bronchiectasis were studied. The associations between MMP-1 polymorphisms, lung function, and disease severity evaluated by high resolution computed tomography (HRCT) were analyzed. Results The frequency of MMP-1(-1607G) allele was significantly higher in patients with bronchiectasis than normal subjects (70.8% vs 45.1%, p<0.01). Forced expiratory volume in 1 second (FEV1) was decreased in bronchiectasis patients with 1G/1G (1.2±0.1 L, n = 14) and 1G/2G (1.3±0.1 L, n = 66) genotypes compared to the 2G/2G genotype (1.7±0.1 L, n = 33, p<0.01). Six minute walking distance was decreased in bronchiectasis patients with 1G/1G and 1G/2G compared to that of 2G/2G genotype. Disease severity evaluated by HRCT score significantly increased in bronchiectasis patients with 1G/1G and 1G/2G genotypes compared to that of 2G/2G genotype. Bronchiectasis patients with at least one MMP-1 (-1607G) allele showed increased tendency for hospitalization. Serum levels of pro-MMP-1, active MMP-1 and TGF-β1 were significantly increased in patients with bronchiectasis with 1G/1G and 1G/2G genotype compared with 2G/2G genotype or normal subjects. Under IL-1β stimulation, peripheral blood monocytes from subjects with 1G/2G or 1G/1G genotype secreted higher levels of TGF-β1compared to subjects with 2G/2G genotype. Conclusion This is the first report to address the influence of MMP-1 polymorphisms on lung function and airway destruction in non-CF bronchiectasis patients. Bronchiectasis patients with MMP-1(-1607G) polymorphism may be more vulnerable to permanent lung fibrosis or airway destruction due to the enhanced MMP-1 and TGF-β1 activity. Upregulated MMP-1 activity results in proteolytic destruction of matrix, and leads to subsequent fibrosis.

[1]  T. Shiomi,et al.  MMP-1 drives immunopathology in human tuberculosis and transgenic mice. , 2011, The Journal of clinical investigation.

[2]  L. Bjermer,et al.  Relationship between matrix production by bronchial fibroblasts and lung function and AHR in asthma. , 2010, Respiratory medicine.

[3]  J. Friedland,et al.  Mycobacterium tuberculosis Upregulates Microglial Matrix Metalloproteinase-1 and -3 Expression and Secretion via NF-κB– and Activator Protein-1–Dependent Monocyte Networks , 2010, The Journal of Immunology.

[4]  K. Chung,et al.  MMP-1(-1607G) polymorphism as a risk factor for fibrosis after pulmonary tuberculosis in Taiwan. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[5]  A. Tomovic,et al.  Matrix Metalloproteinases Gene Variants in Idiopathic Disseminated Bronchiectasis , 2009, Journal of Investigative Medicine.

[6]  Horng-Chyuan Lin,et al.  Matrix metalloproteinase-1 polymorphism in Taiwanese patients with endobronchial tuberculosis. , 2008, Tuberculosis.

[7]  J. Clancy,et al.  A Novel Proteolytic Cascade Generates an Extracellular Matrix-Derived Chemoattractant in Chronic Neutrophilic Inflammation12 , 2008, The Journal of Immunology.

[8]  H. Shimizu,et al.  Interleukin-1beta and macrophage migration inhibitory factor (MIF) in dermal fibroblasts mediate UVA-induced matrix metalloproteinase-1 expression. , 2008, Journal of dermatological science.

[9]  E. Nkenke,et al.  Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma. , 2007, Anticancer research.

[10]  W. Reith,et al.  Proteasome blockade exerts an antifibrotic activity by coordinately down‐regulating type I collagen and tissue inhibitor of metalloproteinase‐1 and up‐regulating metalloproteinase‐1 production in human dermal fibroblasts , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  J. Friedland,et al.  Mycobacterium tuberculosis Up-Regulates Matrix Metalloproteinase-1 Secretion from Human Airway Epithelial Cells via a p38 MAPK Switch1 , 2005, The Journal of Immunology.

[12]  A. Nicholson,et al.  Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. , 2005, The American journal of pathology.

[13]  M. Selman,et al.  MMP-1: the elder of the family. , 2005, The international journal of biochemistry & cell biology.

[14]  J. Shi,et al.  The differential effects of IL-1 and TNF-α on proinflammatory cytokine and matrix metalloproteinase expression in human chondrosarcoma cells , 2004, Inflammation Research.

[15]  William C. Parks,et al.  Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.

[16]  J. Foidart,et al.  Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics , 2004, Laboratory Investigation.

[17]  Hidemi Ito,et al.  Matrix metalloproteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients. , 2004, Sarcoidosis Vasculities and Diffuse Lung Diseases.

[18]  Hal A. Kierstead,et al.  Explicit 2-Factorisations of the Odd Graph , 2004, Order.

[19]  R. Kudo,et al.  A relationship between Matrix metalloproteinase-1 (MMP-1) promoter polymorphism and cervical cancer progression. , 2003, Cancer letters.

[20]  J. Mehta,et al.  TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. , 2003, American journal of physiology. Heart and circulatory physiology.

[21]  N. Kaminski,et al.  Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. , 2003, Nature.

[22]  S. George,et al.  Expression of matrix proteins in an in vitro model of airway remodeling in asthma. , 2003, Allergy and asthma proceedings.

[23]  K. Prikk,et al.  Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF , 2002, European Respiratory Journal.

[24]  Naftali Kaminski,et al.  Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Brinckerhoff,et al.  Erk 1/2 differentially regulates the expression from the 1G/2G single nucleotide polymorphism in the MMP-1 promoter in melanoma cells. , 2002, Biochimica et biophysica acta.

[26]  N. Anthonisen,et al.  The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. , 2002, Human molecular genetics.

[27]  Yoshio Araki,et al.  Interleukin-1β and Tumor Necrosis Factor-α Induce Chemokine and Matrix Metalloproteinase Gene Expression in Human Colonic Subepithelial Myofibroblasts , 2002 .

[28]  A. Andoh,et al.  Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. , 2002, Scandinavian journal of gastroenterology.

[29]  J. Friedland,et al.  Differential regulation of MMP-1/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[30]  C. Brinckerhoff,et al.  High levels of MMP‐1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen‐activated protein kinases in VMM5 melanoma cells , 2002, Journal of cellular biochemistry.

[31]  N. Siafakas,et al.  Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. , 2002, Chest.

[32]  G. Mills,et al.  A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility , 2001 .

[33]  M. Biondi,et al.  Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  M. Selman,et al.  TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? , 2000, American journal of physiology. Lung cellular and molecular physiology.

[35]  Toshiyuki Yamamoto,et al.  Monocyte Chemoattractant Protein-1 Enhances Gene Expression and Synthesis of Matrix Metalloproteinase-1 in Human Fibroblasts by an Autocrine IL-1α Loop1 , 2000, The Journal of Immunology.

[36]  T. Yamamoto,et al.  Monocyte chemoattractant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human fibroblasts by an autocrine IL-1 alpha loop. , 2000, Journal of immunology.

[37]  Y. Nakamura,et al.  Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. , 1999, Cancer research.

[38]  P. Erne,et al.  Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. , 1999, The American journal of physiology.

[39]  P. Erne,et al.  Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-β1 and TGF-β3. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[40]  J. Gusella,et al.  A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. , 1998, Cancer research.

[41]  S. Kivelä,et al.  Bronchiectasis: an orphan disease with a poorly-understood prognosis. , 1997, The European respiratory journal.

[42]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[43]  D. Rannels,et al.  Extracellular matrix biology in the lung. , 1996, The American journal of physiology.

[44]  R. Davies,et al.  The effect of conditioned medium from cultured human bronchial epithelial cells on eosinophil and neutrophil chemotaxis and adherence in vitro. , 1995, American journal of respiratory cell and molecular biology.

[45]  R. Sepper,et al.  Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. , 1995, Chest.

[46]  R. Sepper,et al.  Gelatinolytic and type IV collagenolytic activity in bronchiectasis. , 1994, Chest.

[47]  S. Shapiro,et al.  Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. , 1991, Journal of immunology.

[48]  Coletsos Pj.  Inflammation: a two-edged sword--the model of bronchiectasis. , 1986 .

[49]  P. Cole.  Inflammation: a two-edged sword--the model of bronchiectasis. , 1986, European journal of respiratory diseases. Supplement.